I agree to the Terms of Use , Privacy Notice and Cookie Notice.
(Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total ...
With the Xbox Developer Direct showcase around the corner and the 25th year of Xbox finally underway, Microsoft Gaming CEO ...
Dexcom convinced a federal judge that its phrasing about market share in two statements about sales growth for certain ...
This was the stock's second consecutive day of gains.
NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding DexCom, Inc. (DXCM) class action securities lawsuit A Class Action lawsuit was filed on behalf ...
LOS ANGELES, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the ...
NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: ...
DexCom, incorporated in Delaware and headquartered in San Diego, California, designs, manufactures, and markets continuous glucose monitoring (CGM) systems to help individuals with types 1 and 2 ...
Shares of DexCom Inc. DXCM shed 1.84% to $65.73 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.16% to 6,816.51 and Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results